Plasma fractionation market to grow from $32.75B in 2023 to $72.86B by 2034 at 7.54% CAGR, driven by rising demand for plasma-derived therapies.
Empowering Life Science with Data Driven Decisions
Towards Healthcare is a global leader in technology solutions, clinical research, and advanced analytics focused on life sciences. We form strategic partnerships to deliver insights and innovations that help life science leaders drive research excellence and achieve sustainable growth.
Markdown supported · ⌘↵ to post
No responses yet.